Clin2
NCT06660342Possibly a fitRecruiting

Safety of vonoprazan in pregnant women study

Erosive EsophagitisHeartburnSymptomatic Non-erosive Gastroesophageal Reflux DiseaseHelicobacter Pylori Infection

Treatments studied

Part of Digestive system, Infections, Women’s health & pregnancy clinical trials.

This study looks at the safety of vonoprazan (a medicine for acid reflux) when taken during pregnancy. It follows pregnant women who took the drug and those who didn't, to see how it affects mothers and their babies.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
728 people
Ages
15 years to 50 years
Study type
Observational

Who can take part

  • You are a woman between 15 and 50 years old.
  • You are currently pregnant or have been pregnant recently.
  • You agree to take part in the study and allow your healthcare provider to share your medical records.
  • Either you took vonoprazan during pregnancy (exposed group) or you have a condition that vonoprazan is used to treat but did not take it (unexposed group).
  • You have not been exposed to known harmful medications or experimental drugs during this pregnancy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07752407Not yet recruiting· Phase 3
Vonoprazan for heartburn in non-erosive gerd

This trial tests a new heartburn medicine called vonoprazan (10 mg) compared to a placebo (sugar pill) for people with chronic heartburn but no damage to the esophagus. If you have heartburn at least 4 days a week, you may be able to try this once-daily pill for 24 weeks.

NCT06720610Not yet recruiting· Phase 4
Comparing Two Acid Reflux Medicines for Erosive Esophagitis

This study compares two medications, vonoprazan and esomeprazole, to see which works better for healing damage to the esophagus caused by acid reflux (erosive esophagitis). If you have this condition, this trial could help find you the most effective treatment.

East Jakarta, DKI Jakarta
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07624422Not yet recruiting· Phase 4
Two antibiotic combinations for H. pylori stomach infection

This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.

Damascus
NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang

Hear when a new Erosive Esophagitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.